Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2007
07/25/2007EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents
07/25/2007EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2007EP1322710B9 Modified carbocyanine dyes and their conjugates
07/25/2007CN1328279C Viral inhibitors
07/25/2007CN101006089A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
07/25/2007CN101006088A Fused pyrimidine derivatives and compositions thereof as CXCR3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases
07/25/2007CN101006087A Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
07/25/2007CN101006086A 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido'2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer
07/25/2007CN101005877A Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/25/2007CN101005841A 雄激素受体调节剂 Androgen receptor modulators
07/25/2007CN101005840A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
07/25/2007CN101005838A 大麻素受体配体 Cannabinoid receptor ligands
07/25/2007CN101003535A Alpha hydroxy ¿C alpha phenyl phenylacetic acid 8 ¿C aza dicyclo [3. 2. 1] ¿C 3 heptyl ester, midbody compound, and preparation method
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247641 Compounds, derivatives, compositions, preparation and uses
07/24/2007US7247629 Antitumoral analogs of et-743
07/24/2007US7247628 Cannabinoid receptor ligands and uses thereof
07/24/2007CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives
07/19/2007WO2007082131A1 Process for the preparation of hydroxy substituted heterocycles
07/19/2007WO2007081995A2 Urotensin ii receptor antagonists
07/19/2007WO2007081909A2 Forms of dolasetron mesylate and processes for their preparation
07/19/2007WO2007081907A2 Crystalline forms of dolasetron base and processes for preparation thereof
07/19/2007WO2007081890A2 Production of dolasetron
07/19/2007WO2007081889A2 Production of dolasetron
07/19/2007WO2007081572A2 Inhibitors of checkpoint kinases
07/19/2007WO2007081517A2 Anti-viral compounds
07/19/2007WO2007080324A2 Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
07/19/2007WO2007080191A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
07/19/2007WO2007079957A1 Substituted propiolic acid amides and their use for producing drugs
07/19/2007WO2007079858A1 Cleaning agent comprising complexes with bleach catalytic activity
07/19/2007WO2007041052B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/19/2007US20070167628 Thiazole-2-carboxamide derivatives for use as hippar agonists in the treatment of i.a. dyslipidemia
07/19/2007US20070167627 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
07/19/2007US20070167626 Electron transport compound and organic light emitting device comprising the same
07/19/2007US20070167485 N-benzyl-4-{[(1R)-1,2-dimethylpropyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; phosphodiesterase inhibitor; antiinflammatory, antiallergenic agent; chronic obstructive pulmonary disease (COPD), asthma, or rhinitis
07/19/2007US20070167484 6-Alkoxy-pyrido-pyrimidines
07/19/2007US20070167483 Phenylalanine Enamide Derivatives
07/19/2007US20070167481 Imidazonaphthyridines
07/19/2007US20070167476 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
07/19/2007US20070167455 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
07/19/2007US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments
07/19/2007US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
07/19/2007US20070167445 Androgen receptor modulator compounds and methods
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167442 Such as 1-(1-{3-[4-(ethylsulfonyl)piperazin-1-yl]-3-phenylpropyl}piperidin-4-yl)-5-(methylsulfonyl)-1H-benzimidazole; reductive amination
07/19/2007US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
07/19/2007US20070167435 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders
07/19/2007US20070167434 6,7,8,9-Substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
07/19/2007US20070167427 1,2,4-Triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
07/19/2007CA2635982A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
07/19/2007CA2633752A1 Anti-viral compounds
07/19/2007CA2633722A1 Substituted propiolic acid amides and their use for producing drugs
07/19/2007CA2628186A1 Pyridopyrazine derivatives and the use thereof as medicaments in p13k related diseases
07/19/2007CA2626641A1 Compounds
07/18/2007EP1808435A1 Technical synthesis method for producing tropenol
07/18/2007EP1807428A2 Process for preparing quinoline compounds and products obtained therefrom
07/18/2007EP1807427A2 Substituted indolizines and derivatives as cns agents
07/18/2007EP1807426A2 SUBSTITUTED N-ARYL-1H-PYRAZOLOÝ3,4-b¨QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS
07/18/2007EP1807425A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators
07/18/2007EP1807424A2 Novel kinase inhibitors
07/18/2007EP1807419A1 (2-carboxamido)(3-amino) thiophene compounds
07/18/2007EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
07/18/2007EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/18/2007EP1603912B1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
07/18/2007EP1525204B1 Phenylalanine enamide derivatives
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007EP0938315B1 Immune response modifier compounds for treatment of th2 mediated and related diseases
07/18/2007CN1326858C Novel tricyclic spiropiperidines or spiropyrrolidines
07/18/2007CN1326857C Novel 1,4-diazabicycloalkane derivatives, their preparation and use
07/18/2007CN1326856C Method of preparing inhibitors of phosphodiesterase-4
07/18/2007CN1326855C Ring fused pyrazole derivatives
07/18/2007CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists
07/18/2007CN101001859A Pyrrolopyridine derivatives
07/18/2007CN101001858A S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
07/18/2007CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
07/18/2007CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/18/2007CN101001841A Tetrahydroquinolones and aza-analogues thereof for use as DPP-IV inhibitors in the treatement of diabetes
07/17/2007US7244847 Bactericides
07/17/2007US7244845 Silylating a heterocyclic carboxylic acid, then chlorination, then sulfonation, to produce (R)-2-(4'-isopropoxycarbonylaminobiphenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; matrix metalloproteinase inhibitors
07/17/2007US7244843 Modulators of serotonin receptors
07/17/2007US7244748 Pyridines for treating injured mammalian nerve tissue
07/17/2007US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/17/2007US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/17/2007US7244740 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
07/17/2007US7244734 For example, (3R,9aR)-(3,5-bis(trifluoromethyl)phenyl)-[3-(1H-indol-3-ylmethyl)-7-pyridin-3-yl-1,3,4,8,9,9a-hexahydro-pyrido[1,2-a]pyrazin-2-yl]-methanone; useful in the treatment of disorders in which neurokinins which interact with NK1 receptors, e.g. neurokinin-1 (=Substance P) are involved
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion
07/17/2007CA2303389C Antimicrobial quinolones, their compositions and uses
07/12/2007WO2007079239A2 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
07/12/2007WO2007079086A1 Pyrazoloalkyl substituted imidazo ring compounds and methods
07/12/2007WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
07/12/2007WO2007077949A1 Heterocyclic janus kinase 3 inhibitors
07/12/2007WO2007077931A1 Trisazo compound, ink composition, recording method and colored matter
07/12/2007WO2007077490A2 Bicyclic heteroaryl compounds as pde10 inhibitors
07/12/2007WO2007077313A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them
07/12/2007WO2007077186A1 Pdf inhibitors
07/12/2007WO2007077159A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
07/12/2007WO2007077122A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives
07/12/2007WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors